A recent study suggests that elevated plasma levels of DYRK1A might help prevent neurodegenerative diseases [62], highlighting the potential value of this target in detecting, monitoring, and managing neurodegenerative disorders. This evidence concerns the gene DYRK1A and neurodegenerative disease.